The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study

The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study

A clinical need for aetiotropic coronavirus disease (COVID-19) treatments is required. The immune modulator azoximer bromide (AZB; Polyoxidonium®) is indicated in Russia for use against acute viral infections and during remission. In this study, adults hospitalized with COVID-19 (n=32) received AZB...

Full description

Saved in:
Bibliographic Details
Main Authors: Sergey V Efimov (Author), Natallia V Matsiyeuskaya (Author), Olga V Boytsova (Author), Lyudmila Yu Akhieva (Author), Elena I Kvasova (Author), Francisco Harrison (Author), Yulia S Karpova (Author), Anton Tikhonov (Author), Nadezhda F Khomyakova (Author), Tim Hardman (Author), Jean-François Rossi (Author)
Format: Book
Published: BioExcel Publishing Ltd, 2021-03-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items